Vertex Readies For Major Readouts, With Data Due Soon In Big Pain Market

Phase II LSR Results For Suzetrigine Due By Year End

 
• By Mandy Jackson
  
Vertex may win two new drug approvals in the US in January (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Scrip